These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15180265)

  • 1. Streptozotocin-induced diabetes--a rat model to study involvement of retinal cell types in the onset of diabetic retinopathy.
    Rungger-Brändle E; Dosso AA
    Adv Exp Med Biol; 2003; 533():197-203. PubMed ID: 15180265
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus.
    Tso MO; Cunha-Vaz JG; Shih CY; Jones CW
    Arch Ophthalmol; 1980 Nov; 98(11):2032-40. PubMed ID: 7436840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy.
    Chang YH; Chen PL; Tai MC; Chen CH; Lu DW; Chen JT
    Clin Exp Ophthalmol; 2006 Aug; 34(6):584-9. PubMed ID: 16925707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photobiomodulation Inhibits Long-term Structural and Functional Lesions of Diabetic Retinopathy.
    Cheng Y; Du Y; Liu H; Tang J; Veenstra A; Kern TS
    Diabetes; 2018 Feb; 67(2):291-298. PubMed ID: 29167189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early cellular and molecular changes induced by diabetes in the retina.
    Lorenzi M; Gerhardinger C
    Diabetologia; 2001 Jul; 44(7):791-804. PubMed ID: 11508263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
    Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of Retinal Function in Streptozotocin-induced Diabetic Rats by Using the Electroretinography and Immunohistochemistry Methods].
    Hiramatsu N; Deguchi S; Yoshioka C; Otake H; Yamamoto N; Nagai N
    Yakugaku Zasshi; 2017; 137(9):1169-1175. PubMed ID: 28867704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats.
    Kowluru RA; Odenbach S
    Diabetes; 2004 Dec; 53(12):3233-8. PubMed ID: 15561955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes.
    Armstrong D; al-Awadi F
    Free Radic Biol Med; 1991; 11(4):433-6. PubMed ID: 1797628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy in animal models of diabetes.
    Engerman RL; Kern TS
    Diabetes Metab Rev; 1995 Jul; 11(2):109-20. PubMed ID: 7555563
    [No Abstract]   [Full Text] [Related]  

  • 11. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
    Li J; Wang P; Ying J; Chen Z; Yu S
    Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the influence of angiostatin intravitreal injection on vascular leakage in retina and iris of the experimental diabetic rats.
    Sima J; Ma J; Zhang SX; Guo J
    Yan Ke Xue Bao; 2006 Dec; 22(4):252-8. PubMed ID: 17378159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of P2X(7)-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature.
    Sugiyama T; Kobayashi M; Kawamura H; Li Q; Puro DG
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):1026-32. PubMed ID: 14985326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of retinal vascular permeability in experimental diabetes with genistein.
    Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial reactivity, an early feature of diabetic retinopathy.
    Rungger-Brändle E; Dosso AA; Leuenberger PM
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine.
    Hammes HP; Bartmann A; Engel L; Wülfroth P
    Diabetologia; 1997 Jun; 40(6):629-34. PubMed ID: 9222640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats.
    Barber AJ; Antonetti DA
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5410-6. PubMed ID: 14638745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.
    Hammes HP; Ali SS; Uhlmann M; Weiss A; Federlin K; Geisen K; Brownlee M
    Diabetologia; 1995 Mar; 38(3):269-73. PubMed ID: 7758871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of insulin-mediated vasoprotection: early effect of diabetes on pericyte-containing microvessels of the retina.
    Kobayashi T; Puro DG
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2350-5. PubMed ID: 17460301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.